Received Oct 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLUCELVAX) | SEQIRUS, INC. | UNK | 410515 | LA |
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | UNK | 946913 | LA |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | UNK | y1d03p1 | LA |
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | k4979 | IM / LA |
Anaphylaxis a few minutes after administration. symptoms included difficulty breathing, swollen throat/tongue and gagging. Administered epi-pen twice. Emergency arrived and administered another epinephrine dose.
Asthma
Lamictal, imitrex, covid vaccines
Moderna, last shot on March 13, 2022. Said she had allergic reaction to it.